We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+5.58%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.32B
AUM Growth
-$11.8M
Cap. Flow
-$170M
Cap. Flow %
-5.1%
Top 10 Hldgs %
11.89%
Holding
1,567
New
166
Increased
531
Reduced
576
Closed
161

Top Buys

Rank Stock Value
1
FRX
FOREST LABORATORIES INC
FRX
+$5.63M
2
KMI icon
Kinder Morgan
KMI
+$5.36M
3
IDV icon
iShares International Select Dividend ETF
IDV
+$4.58M
4
JAH
JARDEN CORPORATION
JAH
+$3.44M
5
XPO icon
XPO
XPO
+$3.41M

Top Sells

Rank Stock Value
1
MON
Monsanto Co
MON
+$31.6M
2
KSU
Kansas City Southern
KSU
+$10.1M
3
PWR icon
Quanta Services
PWR
+$10M
4
ORLY icon
O'Reilly Automotive
ORLY
+$9.2M
5
UMBF icon
UMB Financial
UMBF
+$8.11M

Sector Composition

Rank Sector Weight
1 Energy 12.89%
2 Healthcare 10.81%
3 Industrials 9.51%
4 Technology 9.45%
5 Financials 8.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PLM
1401
DELISTED
PolyMet Mining Corp.
PLM
$11K ﹤0.01%
1,000
– –
GRX.RT
1402
DELISTED
GABELLI HEALTHCARE & WELLNESS RT EXP 07/08/2014
GRX.RT
$9K ﹤0.01%
+23,878
New +$8.2K
EGI
1403
DELISTED
Entre Resources Ltd. Common Shares
EGI
$7K ﹤0.01%
22,000
– –
CYHHZ
1404
DELISTED
Community Health Systems, Inc. Series A Contingent Value Rights
CYHHZ
$1K ﹤0.01%
16,672
-14,474
-46% -$942
AIR icon
1405
AAR Corp
AIR
$5.15B
– –
-9,533
Closed -$247K
ANF icon
1406
Abercrombie & Fitch
ANF
$4.17B
– –
-8,215
Closed -$316K
ARCC icon
1407
Ares Capital
ARCC
$13.5B
– –
-14,895
Closed -$263K
ATHE
1408
Alterity Therapeutics
ATHE
$82.3M
– –
-333
Closed -$56K
BBY icon
1409
Best Buy
BBY
$18B
– –
-7,937
Closed -$210K
BGH
1410
Barings Global Short Duration High Yield Fund
BGH
$281M
– –
-8,419
Closed -$202K
BIL icon
1411
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.8B
– –
-16,327
Closed -$1.5M
BKE icon
1412
Buckle
BKE
$2.19B
– –
-4,421
Closed -$202K
BMRN icon
1413
BioMarin Pharmaceuticals
BMRN
$11.5B
– –
-3,214
Closed -$219K
CENX icon
1414
Century Aluminum
CENX
$4.57B
– –
-33,600
Closed -$444K
CI icon
1415
Cigna
CI
$76.6B
– –
-5,307
Closed -$443K
CLNE icon
1416
Clean Energy Fuels
CLNE
$447M
– –
-25,500
Closed -$228K
CRL icon
1417
Charles River Laboratories
CRL
$10.9B
– –
-4,209
Closed -$254K
CSTM icon
1418
Constellium
CSTM
$3.96B
– –
-8,617
Closed -$252K
DAKT icon
1419
Daktronics
DAKT
$941M
– –
-67,820
Closed -$976K
DAN icon
1420
Dana Inc
DAN
$2.91B
– –
-10,000
Closed -$233K
DLR icon
1421
Digital Realty Trust
DLR
$73.7B
– –
-5,015
Closed -$266K
DOMH icon
1422
Dominari Holdings
DOMH
$59.7M
– –
-15
Closed -$63K
DVAX
1423
DELISTED
Dynavax Technologies
DVAX
– –
-1,690
Closed -$30K
EA icon
1424
Electronic Arts
EA
$52.4B
– –
-10,100
Closed -$293K
EBS icon
1425
Emergent Biosolutions
EBS
$375M
– –
-15,500
Closed -$392K
55 56
57
58 59

Similar funds

LGF
LGT Group Foundation Vaduz, Liechtenstein $8.19B AUM 27.7% 1-Year Est. Return
CCM
Causeway Capital Management Los Angeles, California $8.15B AUM 29.28% 1-Year Est. Return
CL
Choreo LLC Rockford, Illinois $8.15B AUM 20.12% 1-Year Est. Return
WJWM
Williams Jones Wealth Management New York $8.14B AUM 19.32% 1-Year Est. Return
CLOS
Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $8.13B AUM 26.03% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
CCM
Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return
KPWS
Kestra Private Wealth Services Austin, Texas $8.11B AUM 24.74% 1-Year Est. Return

Oppenheimer & Co's Q2 2014 Portfolio in Review

As of Q2 2014, Oppenheimer & Co held 1,567 positions worth $3.32B, down 0.35% from $3.34B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Oppenheimer & Co withdrew a net $170M in Q2 2014, closing 161 positions and reducing 576 holdings. Its most notable exit was O'Reilly Automotive, an estimated $9.2M position sold in full.

By sector, the portfolio is most concentrated in Energy at 13% of assets, up from 12% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Oppenheimer & Co opened a new position in FOREST LABORATORIES INC worth $5.98M.

  • Oppenheimer & Co's largest Q2 2014 buy was FOREST LABORATORIES INC: 60,413 shares worth $5.98M.
  • Oppenheimer & Co added most to Kinder Morgan in Q2 2014, an estimated $5.36M increase.
  • Oppenheimer & Co's biggest Q2 2014 reduction was Monsanto Co, cutting an estimated $31.6M.
  • Oppenheimer & Co fully exited O'Reilly Automotive in Q2 2014, selling an estimated $9.2M.
  • Oppenheimer & Co's ten largest holdings make up 12% of its $3.32B portfolio in Q2 2014.
  • Oppenheimer & Co opened 166 new positions and closed 161 in Q2 2014.
  • Oppenheimer & Co's portfolio value fell 0.35% quarter-over-quarter to $3.32B.

Based on Oppenheimer & Co's 13F filing for Q2 2014, filed 14 Aug 2014.